The heteromeric kinesins constitute a subfamily of kinesinrelated motor complexes that function in several distinct intracellular transport events. The founding member of this subfamily, heterotrimeric kinesin II, has been purified and characterized from early sea urchin embryos, where it was shown using antibody perturbation to be required for the synthesis of motile cilia, presumably by driving the anterograde transport of raft complexes. To further characterize heteromeric kinesin transport pathways, and to attempt to identify cargo molecules, we are using the model organism Caenorhabditis elegans to exploit its well-characterized nervous system and simple genetics. Here we describe methods for largescale nematode growth and partial purification of kinesinrelated holoenzymes from C. elegans, and an in vivo transport assay that allows the direct labeling and visualization of motor complexes and putative cargo molecules moving in living C. elegans neurons. This transport assay is being used to characterize the in vivo transport properties of motor enzymes in living cells, and to exploit a number of existing mutations in C. elegans that may represent constituents of heteromeric kinesin-driven transport pathways, for example, the retrograde intraflagellar transport motor CHE-3 dynein, as well as cargo molecules and/or regulatory molecules.
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Microtubule (MT)-based molecular motors are mechanochemical holoenzymes that provide the force responsible for driving a number of cellular processes, and are separated into two broad classes: the kinesins and the dyneins. The kinesins constitute a superfamily of motor enzymes that are involved in diverse intracellular transport events, ranging from mitotic spindle formation and maintenance, to organelle positioning, vesicle transport, and intraflagellar transport (IFT) (1) . Kinesins use energy liberated from ATP hydrolysis to move cargo along MTs; this motor activity occurs through conserved motor domains, which are in turn linked to divergent tails containing cargo binding and dimerization domains (1) . Kinesin and kinesin-related polypeptides self-assemble into multimeric complexes to form functional holoenzymes, which may contain nonmotor polypeptides such as light chains and accessory polypeptides. Increasing numbers of kinesin family holoenzymes have been purified in their native state from various sources, and demonstrate a range of oligomeric states. The dynein superfamily of molecular motors includes both axonemal and cytoplasmic dyneins, which move toward the minus ends of MTs and generate the force required to drive the beating of motile cilia and flagella and to facilitate retrograde intracellular trafficking, respectively (2) . Dyneins are large-molecular-mass protein complexes, typically composed of two dynein heavy chain motor subunits and a variable number of nonmotor accessory subunits including intermediate chains, light intermediate chains, and light chains. A subfamily of kinesins called the heteromeric kinesins and a family of dyneins called the class DHC1b dyneins are the focus of work described here.
The heteromeric kinesins are a subfamily of kinesin-related polypeptides found in multiple organisms, and are important transport motors required for diverse functions such as the synthesis and maintenance of motile cilia and flagella and immotile sensory cilia (3, 4) , for the dispersion of melanosomes in pigment cells (5) , and for the transport of choline acetyltransferase (ChAT) in some adrenergic neurons (6) ( Table 1 ). The founding member of this subfamily, kinesinII, was first purified from sea urchin eggs and embryos and proved to be unique in that it is heterotrimeric, consisting of two distinct motor subunits, SpKRP 85 and SpKRP 95 , which heterodimerize via ␣-helical coiled coils in their stalk domains, and associate with a nonmotor accessory polypeptide, SpKAP (4, 7, 8) (Fig. 1) . Purified sea urchin kinesinII moves toward the plus ends of MTs at a rate of 0.4 -0.6 m/s in vitro, and has been visualized using rotary shadow electron microscopy, indicating that the two motor subunits lie at one end of the molecule and are linked by a rod to the globular accessory polypeptide (7) (8) (9) .
The DHC1b class of dyneins represent a divergent isotype of cytoplasmic dyneins that are placed phylogenetically between axonemal and cytoplasmic classes of DHC (10) . DHC1b members have been implicated in retrograde transport in motile cilia and flagella and immotile sensory cilia (3, 10, 11) , and are expressed in both ciliated and nonciliated cells (10) .
The purification of kinesinII from urchin eggs and embryos has been feasible due to the large maternal contribution proteins required for early embryonic development. Although sea urchins are amenable to biochemical purification of kinesins, elucidation of kinesinII function and identification of cargoes have relied on antibody perturbation techniques, which has demonstrated a role of kinesinII in the synthesis of motile cilia in developing sea urchin embryos (12) (Fig. 1) . The purification and characterization of sea urchin kinesinII has been described in detail by Meyer et al. (13) . While many questions remain concerning the function and mechanisms of action of kinesinII in sea urchin embryos, we are now investigating kinesinII function in the nematode Caenorhabditis elegans, because it is genetically malleable and readily expresses transgenes. Here we describe methods for investigating the structure and function of heteromeric kinesins in C. elegans, and their putative cargo molecules, using biochemical and transgenic techniques and an in vivo transport assay.
Using the purification methods described here, we recently described the existence of two heteromeric kinesin complexes in C. elegans: a bona-fide heterotrimeric kinesinII homolog, and a dimeric complex, Osm-3-kinesin, which both localize to immotile sensory cilia that constitute the terminal dendritic endings of amphid and phasmid chemosensory neurons (14) (Fig. 2) . Although kinesinII is routinely purified in Ն200-g yields from sea urchin cytosol, kinesinII and Osm-3-kinesin are not abundant in C. elegans lysates, since they are expressed in only a small subset of cells. Thus, although we were able to characterize the hydrodynamic properties of C. elegans heteromeric kinesins by partial purification, and in turn use that information to make predictions about their molecular architecture (14), we were unable to purify them to homogeneity using the starting volumes described here. However, more abundant motors may be readily purified from C. elegans cytosol, and we have previously obtained a highly purified sample of conventional kinesin using these same methods and starting volumes (14) . Our work underscores one limitation of the C. elegans system, and suggests that sea urchin embryos are more amenable to the biochemical analysis of purified kinesinII.
To further our understanding of kinesinII function in worms, we have developed an assay that allows us to directly visualize the in vivo transport of kinesinII and putative cargo molecules moving along cytoplasmic and axonemal MTs in dendrites and sensory cilia of chemosensory neurons of living C. elegans (11, 15) (Fig. 3 ). This in vivo transport assay makes use of transgenic lines of worms expressing kinesinII polypeptides and cargo directly fused to the green fluorescent protein (GFP) and time-lapse fluorescent microscopy. This assay has already been valuable in showing that kinesinII and two of its presumptive cargoes share the same transport velocities in dendrites and sensory cilia, moving ϳ0.6 m/s in the anterograde direction and ϳ1.1 m/s in the retrograde direction (11, 15) . Additionally, expressing these fusion proteins in mutant backgrounds and assaying for defects in transport allow for the rapid identification of other components involved in heteromeric kinesin transport pathways. Using this approach we have shown a specific requirement for the DHC1b class cytoplasmic dynein in the retrograde transport/retrieval of kinesinII and associated cargo in cilia, but not dendrites (11).
METHODS

Large-Scale Growth of C. elegans in Liquid Culture
We typically grow worms in 16-liter cultures for further biochemical procedures, using methods modified from those described by Lye et al. (16) . We first grow wild-type worms (N2 strain; Caenorhabditis Genetics Center (CGC), University of Minnesota, St. Paul) to high density on 5-10 large (15 cm) standard NGM-agar plates (17) which are seeded with the Escherichia coli strain NA22 (CGC). Although it is customary to use E. coli strain OP50 for C. elegans growth, the NA22 strain is preferred for liquid cultures because it does not form chains/aggregates in liquid culture. The worms are washed off of the plates with S-basal medium (16) (19.3 mM K 2 HPO 4 , 25 mM KH 2 PO 4 , 100 mM NaCl, 0.01 mg/ml cholesterol, pH 6.8), then used to inoculate a sterile 16-liter culture of S-basal medium in a large Belco Spinner Flask (Belco Glass, Vineland, NJ) equipped with a motorized stir blade, which has been preaerated using house air supplies bubbled through an airstone accessory. Preaeration is typically performed for 2-4 h prior to inoculation. The nema- 
FIG. 2.
Schematic representation of two heteromeric kinesin complexes expressed in C. elegans chemosensory neurons: kinesinII and Osm-3-kinesin. Using methods described here for largescale nematode growth and biochemical analysis, we predict that kinesinII is heterotrimeric with two nonidentical motor subunits (KRP95 and KRP85) and a nonmotor accessory polypeptide (KAP), and that Osm-3-kinesin is dimeric, containing the OSM-3 motor polypeptide.
todes are added to the 16-liter culture and stirred in the absence of food for 30 min for acclimation, then NA22 E. coli are added daily in 30-to 35-g quantities until the worms are harvested (see below for NA22 preparation). At each feeding, 1 ml of Antifoam C (Sigma, St. Louis, MO) should be added to prevent foaming. The culture should be examined several times daily to ensure that the food has not been exhausted; if clearing of the medium is seen, then additional E. coli should be added. The nematodes are cultured with continuous aeration (house air and stirring) at 20 -25°C until near saturation but without starving (monitored by cloudiness of the culture medium and examination of the worms for dauer larvae formation). A culture typically grows to saturation by approximately 4 -5 days postinoculation at 25°C, and once saturated, the worms are settled by placing the culture at 4°C for 8 -12 h, and the nematode-free medium is aspirated. The worms are then pelleted with low-speed centrifugation (1000g) and washed two or three times in the buffer to be used for extraction. Alternatively, if a lowtemperature settling is not favored, then the worms can be harvested immediately by collecting the 
Worm Food Preparation
The NA22 E. coli used for food are grown in 16 liter batches using sterile Terrific Broth (18) stirred in a Belco Spinner flask with aeration as described above. The bacteria are cultured overnight at room temperature or, preferably, at 37°C. The saturated bacteria culture is pelleted at 3000g then resuspended in sterile S-basal buffer and stored at 4°C until further use. We typically use only bacteria less than 2 weeks old.
Biochemical Purification of C. elegans Motor Holoenzymes
Heteromeric kinesins and conventional kinesin holoenzymes may be purified or partially purified from C. elegans extracts using a MT affinity scheme modified from that described by Cole et al. (8) (Fig.   4) . Nematodes pelleted from 16 liter cultures are washed twice in PMEG extraction buffer [100 mM Pipes, 2.5 mM MgSO 4 , 0.5 mM EDTA, 5 mM EGTA, 1 mM dithiothreitol (DTT), 0.9 M glycerol, pH 6.9, supplemented with protease inhibitors: 10 g/ml leupeptin, 2 g/ml aprotinin, 1 g/ml pepstatin, 20 g/ml benzamidine, 1 mg/ml N ␣ -p-tosyl-L-arginine methyl ester (TAME), 0.1 mM PMSF, and 0.1 mg/ml soybean trypsin inhibitor]. After washing, the worm pellet is resuspended in 2ϫ volume (w/v) of PMEG and lysed by French press homogenization at 8000 -10,000 psi. The lysate is clarified by spinning at 50,000g for 45 min (discard pellet and aspirate lipid layer), and the supernatant centrifuged again at 150,000g for 60 min.
MTs are polymerized in the clarified worm extract, which then acts as an affinity matrix for purifying kinesin and kinesin-related proteins in an ATP-dependent purification process. This technique uses the MT binding properties of kinesin: kinesin binds in a rigor complex to MTs in the presence of the nonhydrolyzable ATP analog AMPPNP, and is released with the addition of ATP. Therefore, AMP-
FIG. 4.
General scheme for the purification of kinesin holoenzymes from C. elegans cytosol. MT-associated proteins are selectively removed from total extract by cosedimentation with taxol-stabilized MTs in the presence of AMPPNP, and eluted with the addition of ATP. Eluted kinesin-related holoenzymes may be then further fractionated by FPLC and sucrose gradient ultracentrifugation.
PNP is used to cosediment MT-associated proteins (MAPs) with taxol-stabilized MTs, and motors are selectively released into the supernatant with the addition of ATP. To prevent added AMPPNP from competing with endogenous ATP pools in the extract, we first supplement the lysate with 1 U/ml hexokinase and 50 mM glucose to deplete ATP. This is followed by the addition of 2 mM GTP and 20 M taxol to assemble MTs from endogenous tubulin, which is performed at 16°C for 20 min with gentle rocking. MAPs are bound to the MTs with the addition of 2 mM AMPPNP and an additional incubation of 25 min at 16°C. The MTs and associated proteins are then pelleted through a 15% sucrose cushion (15% w/v in PMEG, supplemented with 100 M GTP, 100 M AMPPNP, and 1 M taxol) at 20,000g for 60 min at 10°C. The MT/MAP pellet is then washed briefly in PEG buffer (PMEG without MgSO 4 and EDTA to 15 mM) supplemented with 100 M GTP, 1 M taxol, and 100 M AMPPNP, using a syringe and 18-to 22-gauge needles, and the MTs/MAPs repelleted at 30,000g for 25 min at 10°C. Finally, the bound motors are eluted for 4 -6 h at 4°C by complete resuspension in elution buffer: 10 mM ATP, 10 mM MgSO 4 , and 200 mM KCl in PME (PMEG without glycerol), supplemented with 1 mM GTP and 10 M taxol. The MTs are removed by centrifugation (40,000g, 20 min at 4°C), and the motor-containing supernatant is saved.
The supernatant is further fractionated by two steps of chromatography. The eluted motors from above are first separated using FPLC-Superose-6 gel filtration chromatography (Pharmacia), and the fractions analyzed by immunoblot analysis using specific antibodies. Peak fractions are pooled and dialyzed extensively into a low-ionic-strength buffer (20 mM Tris, 0.5 mM EDTA, 2.5 mM MgSO 4 , 1 mM DTT), followed by fractionation using FPLC-Mono-Q anion-exchange chromatography (Pharmacia), eluting in a salt gradient of 0 -500 mM NaCl. Peak fractions for kinesin and heteromeric kinesins are concentrated using Biomax (Millipore, Bedford, MA) or Nanosep (Pall Filtron, Northborough, MA) protein concentrators, then loaded separately onto 5-20% linear sucrose gradients (w/v in the low-ionicstrength buffer above) and separated by ultracentrifugation. The final sucrose gradient fractions are analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis. C. elegans heterotrimeric kinesinII and dimeric Osm-3-kinesin are expressed in only a subset of neurons and are therefore difficult to purify to homogeneity due to their low abundance; however, we have been able to purify conventional kinesin to homogeneity in quantities sufficient for further characterization (i.e., motility assays). For example, starting with cytosol from a 16 liter culture containing ϳ2.6 g of total protein, we are able to obtain a AMPPNP MT/MAP pellet containing ϳ50 mg total protein, from which ϳ3.7 mg of protein is eluted with the addition of ATP. In this ATP eluate, conventional kinesin represents ϳ1 mg (25%), and ϳ0.5 mg highly purified kinesin is recovered from the final sucrose gradient centrifugation step in a monodisperse peak.
Heteromeric Function Analysis
The functional analysis of heteromeric kinesins in C. elegans has been accomplished by directly labeling heteromeric kinesin polypeptides and putative cargo molecules with GFP, and monitoring their movement in an in vivo motility assay in living worms. This is accomplished by creating a translational fusion of heteromeric kinesin/cargo polypeptides with GFP, expressed under the control of endogenous promoters (Fig. 5) . For example, the C. elegans kinesinII accessory polypeptide, KAP, and presumptive cargo polypeptides, OSM-1 and OSM-6, have been visualized moving in vivo using the methods described below. To generate transgenic worms expressing KAP::GFP fusion proteins we isolated a genomic fragment containing the entire open reading frame for KAP plus 1.5 kb of upstream sequence from a genomic cosmid provided by the C. elegans genome sequencing consortium using a combination of standard molecular biology techniques (Pfu polymerase chain reaction amplification and standard restriction digests) (18) . This large genomic fragment was placed upstream and in-frame with the GFP gene in the C. elegans transformation vector pPD 95.75 (kindly provided by Andrew Fire, Carnegie Institute of Washington, Baltimore, MD). The aforementioned vector was then injected into the syncytial gonad of a wild-type adult hermaphrodite worm at a concentration of 100 g/ml (19) . As a cotransformation marker we typically use plasmid pRF4 (also at 100 g/ml), which contains the semidominant collagen mutation rol-6 (su1006) (20) and causes a "roller" phenotype; however, several excellent alternatives may be used and are described by Mello and Fire (21) Transgenic roller hermaphrodites were picked from the F 1 progeny of injected worms, and F 2 heritable roller lines are selected from the self progeny of F 1 rollers. These heritable lines were then examined for GFP fluorescence using standard epifluorescence microscopy and laser scanning confocal microscopy.
In Vivo Transport Assay
Time-lapse fluorescence microscopy is used to monitor the in vivo movement of these GFP-tagged motor and cargo molecules in living C. elegans neurons (11, 15) . Heritable stocks of worms expressing the GFP-fusion protein of interest are maintained by self-fertilization of the adult hermaphrodite. For the in vivo transport assay, several adult transgenics are picked from a growing culture and placed in a drop of M9 buffer (40 mM Na 2 HPO 4 , 20 mM KH 2 PO 4 , 80 mM NaCl, 1 mM MgSO 4 ⅐ 7H 2 0) on poly-(L-lysine)-coated slides. To prepare slides, approximately 20 l of poly-(L-lysine) (Sigma) is added to a freshly cleaned and dried slide, and spread evenly. The poly-(L-lysine) is allowed to dry, then the slides are washed briefly in water to remove trace azide (or other preservatives) that may be toxic to the nematodes. Once the worms are in the drop of M9 buffer, a mouth aspirator with a pulled capillary is used to aspirate most of the extra M9 buffer, leaving enough so that the worms remain hydrated; this is followed immediately by the addition of 20 l of 1-10 mM levamisole (Sigma) made in M9 buffer. The worms will immediately stop movement in the anesthetic, and working quickly, a coverslip is added carefully and the extra buffer wicked from the edges of the coverslip with a Kimwipe. The wicking of the extra buffer is important so that the worms will lie flat on the poly-(L-lysine) surface. Paralyzed, nontwitching worms are selected on the slide at 10ϫ magnification, and in vivo transport is imaged at 100ϫ magnification. The movement of GFP particles is visualized by collecting fluorescent images at 1 frame/s or 1 frame/0.5 s intervals using a Nikon Eclipse E600 microscope (Nikon Corp., Tokyo, Japan) equipped with a Uniblitz automated shutter driver and Metamorph Imaging System software (Universal Imaging Corp., WestChester, PA). Images are collected for a minimum of 1 min, and movies created from stacked images using Metamorph imaging software. Velocities of transport are then determined by analyzing time-lapse transport movies for moving "dots" of fluorescence. The relative positions of individual fluorescent particles are monitored over four or more frames, and velocities calculated by determining total distance moved per given period using an objective micrometer.
We routinely use 10 mM levamisole, rather than the 1 mM concentration that is often used with C. elegans, to completely inhibit twitching and thus to facilitate microscopic observations of transport. It is important to work quickly, since the nematodes are compromised in prolonged exposure to levamisole. We typically monitor transport for only 10 min or less; after 10 min we begin to see nonmoving GFP aggregates in the neurons, which may represent inactivation of the motors required for their movement. We have performed transport assays in 1, 2, and 10 mM concentrations of levamisole and have not seen any differences in the transport velocities for two GFP-tagged proteins, and the worms fully recover after shifting from as high as 100 mM levamisole to anesthetic-free buffer. However, the amount of time required for recovery does differ significantly; for example, worms treated with 1 mM levamisole fully recover within 2 h of shifting to anesthetic-free M9 buffer, whereas worms treated with 10 mM levamisole have only 50% recovery at 8 h, but full recovery within 24 h (full recovery as measured by normal worm movement, feeding, and egg laying). In these viability tests, we soaked worms for 5 or 10 min in levamisole, corresponding to the length of our transport assays, and saw full recovery in 100% of worms treated; however, full recovery was also seen with worms treated longer than 10 min.
Summary of Results
Using the above-mentioned in vivo transport assay, we have directly labeled and characterized the bidirectional transport of kinesinII and two presumptive cargo molecules, OSM-1 and OSM-6, in C. elegans chemosensory neurons (11, 15) (Fig. 3) . To summarize, we have used this assay in conjunction with various mutants in sensory cilia function to develop a model for the intradendritic and intraflagellar transport required for sensory cilia synthesis and function in these neurons, which involves kinesinII as the anterograde motor driving the transport of IFT rafts from the neuronal cell body to the tip of the cilia, and cytoplasmic dynein DHC1b as the retrograde retrieval motor driving the retrieval of kinesinII and associated raft particles specifically in cilia, but not in associated dendrites (11).
CONCLUSIONS
We have described methods to analyze the structure-function of kinesin-related motor complexes in C. elegans. These nematodes may be grown in large liquid cultures and are amenable to biochemistry required for the characterization of motor holoenzymes (i.e., oligomeric state and subunit composition), and this information may then be used to directly test function using molecular and transgenic methods. Specifically, we have developed an in vivo transport assay that allows us to directly visualize the movement of specific MTbased motors and putative cargoes moving in living C. elegans neurons. This assay has allowed us to characterize both intradendritic and intraflagellar transport driven by kinesinII and a DHC1b cytoplasmic dynein in chemosensory neurons. We anticipate that the ability to directly visualize motor movement in vivo will serve as an informative biophysical assay and, when used in conjunction with mutants, will allow us to further elucidate this transport pathway.
